International Trade Today is a service of Warren Communications News.
Subscriber Login
FDA
to
Refine Category Search
Clear Terms

Search Primer

Multi-word term: Place inside quotes to ensure an exact match together (e.g. "China import").

Term list: Separate terms with spaces, not commas or semicolons to find either word (e.g. AD/CVD antidumping).

Acronyms: Use all capital letters (e.g., ACE).

Required term: If a term must be included in any resulting articles, prefix it with a plus sign (e.g., CBP +releases).

Excluded term: If a term should be excluded from any articles being found, prefix it with a minus sign (e.g., -ruling).

Singular form: Use the singular form when doing multi-word terms (e.g. "russian export control" instead of "russian export controls").

Shortest word form: When you have different word forms in a quoted term, include the shortest version if it is the last part of the expression (e.g., "entity list" instead of "entity listing" or "entity listed").

FDA Recognizes Drug Facility Inspections by Eight EU Countries
November 2, 2017 |FDA

The Food and Drug Administration will recognize inspections of pharmaceutical manufacturing facilities by eight countries in the European Union, it said. The agency has determined that regulatory authorities in Austria, Croatia, France, Italy, Malta, Spain, Sweden and the United Kingdom are “capable of conducting inspections of manufacturing facilities that meet FDA requirements,” it said. FDA will begin relying on data from inspections by those countries to determine the compliance of pharmaceutical and pharmaceutical ingredient manufacturers beginning Nov. 1, it said.

FDA Proposes to Disallow Soy Protein Health Claims on Food Labeling, May Allow 'Qualified' Claims
October 31, 2017 |FDA

The Food and Drug Administration is proposing to revoke a regulation authorizing the use on food labeling of health claims that eating soy protein reduces the risk of heart disease, it said. According to the agency’s proposed rule, evidence has emerged since the health claim was authorized in 1998 that contradicts the finding that soy protein encourages heart health. If FDA finalizes its rule, it “intends to allow the use of a qualified health claim as long as there is sufficient evidence to support a link between eating soy protein and a reduced risk of heart disease,” FDA Center for Food Safety and Nutrition Director Susan Mayne said in a statement. “A qualified health claim, which requires a lower scientific standard of evidence than an authorized health claim, would allow industry to use qualifying language that explains the limited evidence linking consumption of soy protein with heart disease risk reduction.”